Geode Capital Management’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.48M Sell
510,699
-14,170
-3% -$41.1K ﹤0.01% 3218
2025
Q1
$378K Buy
524,869
+43,741
+9% +$31.5K ﹤0.01% 3645
2024
Q4
$496K Sell
481,128
-59
-0% -$61 ﹤0.01% 3603
2024
Q3
$645K Sell
481,187
-11,000
-2% -$14.7K ﹤0.01% 3513
2024
Q2
$640K Buy
492,187
+22,746
+5% +$29.6K ﹤0.01% 3480
2024
Q1
$808K Buy
469,441
+56,734
+14% +$97.6K ﹤0.01% 3442
2023
Q4
$607K Hold
412,707
﹤0.01% 3542
2023
Q3
$500K Buy
412,707
+21,902
+6% +$26.5K ﹤0.01% 3605
2023
Q2
$567K Buy
390,805
+52,949
+16% +$76.8K ﹤0.01% 3593
2023
Q1
$490K Buy
337,856
+80,572
+31% +$117K ﹤0.01% 3653
2022
Q4
$445K Sell
257,284
-32,974
-11% -$57K ﹤0.01% 3711
2022
Q3
$580K Hold
290,258
﹤0.01% 3645
2022
Q2
$215K Sell
290,258
-180,931
-38% -$134K ﹤0.01% 4212
2022
Q1
$4.1M Buy
471,189
+14,005
+3% +$122K ﹤0.01% 2914
2021
Q4
$7.32M Buy
457,184
+12,270
+3% +$196K ﹤0.01% 2657
2021
Q3
$8.19M Buy
444,914
+31,153
+8% +$573K ﹤0.01% 2606
2021
Q2
$5.78M Buy
413,761
+50,150
+14% +$700K ﹤0.01% 2814
2021
Q1
$5.35M Buy
363,611
+5,463
+2% +$80.4K ﹤0.01% 2757
2020
Q4
$6.94M Buy
358,148
+158,719
+80% +$3.08M ﹤0.01% 2403
2020
Q3
$2.23M Buy
199,429
+2,729
+1% +$30.4K ﹤0.01% 2822
2020
Q2
$2.66M Buy
196,700
+41,476
+27% +$561K ﹤0.01% 2687
2020
Q1
$1.25M Buy
155,224
+35,772
+30% +$289K ﹤0.01% 2918
2019
Q4
$1.15M Buy
119,452
+2,670
+2% +$25.7K ﹤0.01% 3231
2019
Q3
$1.24M Buy
116,782
+2,065
+2% +$21.9K ﹤0.01% 3154
2019
Q2
$1.32M Buy
114,717
+20,376
+22% +$234K ﹤0.01% 3141
2019
Q1
$1.21M Buy
94,341
+2,499
+3% +$32K ﹤0.01% 3083
2018
Q4
$564K Buy
91,842
+3,876
+4% +$23.8K ﹤0.01% 3326
2018
Q3
$924K Buy
87,966
+34,476
+64% +$362K ﹤0.01% 3251
2018
Q2
$784K Buy
53,490
+33,094
+162% +$485K ﹤0.01% 3278
2018
Q1
$290K Buy
+20,396
New +$290K ﹤0.01% 3579